-
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Analysts
Source: Buzz FX / 29 Dec 2024 01:51:12 America/Chicago
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat December 29, 2024 Share Link copied to clipboard. Rocket Pharmaceuticals, Inc. ( NASDAQ:RCKT - Get Free Report ) has receive
Read more...